Studies in rodents revealed that ω3 PUFAs contributed to obesity phenotype improvements, including WAT inflammation, insulin sensitivity, glucose tolerance, and colonic inflammation, by targeting gut microbiota [213,214]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.